Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211 by Gulick, Roy M., Su, Zhaohui, Flexner, Charles, Hughes, Michael D., Skolnik, Paul R., Wilkin, Timothy J., Gross, Robert, Krambrink, Amy, Coakley, Eoin, Greaves, Wayne L., Zolopa, Andrew, Reichman, Richard, Godfrey, Catherine, Hirsch, Martin, Kuritzkes, Daniel R.

Get full text

Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovir... by Duerr, Ann, Huang, Yunda, Buchbinder, Susan, Coombs, Robert W., Sanchez, Jorge, del Rio, Carlos, Casapia, Martin, Santiago, Steven, Gilbert, Peter, Corey, Lawrence, Robertson, Michael N.

Get full text

Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection by Janes, Holly, Friedrich, David P., Krambrink, Amy, Smith, Rebecca J., Kallas, Esper G., Horton, Helen, Casimiro, Danilo R., Carrington, Mary, Geraghty, Daniel E., Gilbert, Peter B., McElrath, M. Juliana, Frahm, Nicole

Get full text

Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095 by Schouten, Jeffrey T., Krambrink, Amy, Ribaudo, Heather J., Kmack, Anne, Webb, Nancy, Shikuma, Cecilia, Kuritzkes, Daniel R., Gulick, Roy M.

Get full text

Response to Vicriviroc in Treatment-Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211 by Su, Zhaohui, Gulick, Roy M., Krambrink, Amy, Coakley, Eoin, Hughes, Michael D., Han, Dong, Flexner, Charles, Wilkin, Timothy J., Skolnik, Paul R., Greaves, Wayne L., Kuritzkes, Daniel R., Reeves, Jacqueline D.

Get full text

Interruption of Antiretroviral Treatment in HIV-Infected Patients with Preserved Immune Function Is Associated with a Low Rate of Clinical Progression: A Prospective Study by AIDS... by Skiest, Daniel J., Zhaohui Su, Havlir, Diane V., Robertson, Kevin R., Coombs, Robert W., Cain, Pat, Peterson, Tianna, Krambrink, Amy, Jahed, Nasreen, McMahon, Deborah, Margolis, David M.

Get full text

Detection of Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy by Hare, C. Bradley, Mellors, John, Krambrink, Amy, Su, Zhaohui, Skiest, Daniel, Margolis, David M., Patel, Sheran S., Barnas, Douglas, Frenkel, Lisa, Coombs, Robert W., Aweeka, Francesca, Morse, Gene D., Haas, David W., Boltz, Valerie, Palmer, Sarah, Coffin, John, Havlir, Diane V.

Get full text

Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211 by Tsibris, Athe M. N., Paredes, Roger, Chadburn, Amy, Su, Zhaohui, Henrich, Timothy J., Krambrink, Amy, Hughes, Michael D., Aberg, Judith A., Currier, Judith S., Tashima, Karen, Godfrey, Catherine, Greaves, Wayne, Flexner, Charles, Skolnik, Paul R., Wilkin, Timothy J., Gulick, Roy M., Kuritzkes, Daniel R

Get full text

Response to Vicriviroc in Treatment-Experienced Subjects Using an Enhanced Sensitivity Co-receptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211 by Su, Zhaohui, Gulick, Roy M., Krambrink, Amy, Coakley, Eoin, Hughes, Michael D., Han, Dong, Flexner, Charles, Wilkin, Timothy J., Skolnik, Paul R., Greaves, Wayne L., Kuritzkes, Daniel R., Reeves, Jacqueline D.

Get full text

Detection of Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of VirologicaUy Suppressive Antiretroviral Therapy by Hare, C. Bradley, Mellors, John, Krambrink, Amy, Su, Zhaohui, Skiest, Daniel, Margolis, David M., Patel, Sheran S., Barnas, Douglas, Frenkel, Lisa, Coombs, Robert W., Aweeka, Francesca, Morse, Gene D., Haas, David W., Boltz, Valerie, Palmer, Sarah, Coffin, John, Havlir, Diane V.

Get full text

Interruption of Antiretroviral Treatment in HIVInfected Patients with Preserved Immune Function Is Associated with a Low Rate of Clinical Progression: A Prospective Study by AIDS C... by Skiest, Daniel J, Su, Zhaohui, Havlir, Diane V, Robertson, Kevin R, Coombs, Robert W, Cain, Pat, Peterson, Tianna, Krambrink, Amy, Jahed, Nasreen, McMahon, Deborah, Margolis, David M

Get full text

Detection of Nonnudeoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy by HARE, C. Bradley, MELLORS, John, AWEEKA, Francesca, MORSE, Gene D, HAAS, David W, BOLTZ, Valerie, PALMER, Sarah, COFFIN, John, HAVLIR, Diane V, KRAMBRINK, Amy, ZHAOHUI SU, SKIEST, Daniel, MARGOLIS, David M, PATEL, Sheran S, BARNAS, Douglas, FRENKEL, Lisa, COOMBS, Robert W

Get full text

Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-infected, treatment-experienced patients : AIDS clinical trials group 5211. Commentary by CLOTET, Bonaventura, GULICK, Roy M, GREAVES, Wayne L, ZOLOPA, Andrew, REICHMAN, Richard, GODFREY, Catherine, HIRSCH, Martin, KURITZKES, Daniel R, ZHAOHUI SU, FLEXNER, Charles, HUGHES, Michael D, SKOLNIK, Paul R, WILKIN, Timothy J, GROSS, Robert, KRAMBRINK, Amy, COAKLEY, Eoin

Get full text